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This review, written on the occasion of the 70th anniversary of the Institute for General Reanimatology of the Russian Academy
of Medical Sciences, provides an update of recent research in the field of resuscitation medicine carried out at the Safar Center
for Resuscitation Research at the University of Pittsburgh School of Medicine. Current and recent studies describing bench
to bedside investigation in the areas of traumatic brain injury (TBI), cardiopulmonary arrest, hemorrhagic shock, and ultra!
novel approaches to resuscitation are discussed. Investigation in TBI across a variety of topics by many investigators includ!
ing mechanism of neuronal death, oxidative and nitrative stress, proteomics, adenosine, serotonin, novel magnetic resonance
imaging application, inflicted childhood neurotrauma, and TBI rehabilitation is addressed. Research discussed in the program
of cardiopulmonary arrest includes optimization of the use of mild hypothermia and novel investigation in experimental
asphyxial cardiac arrest. In the program on hemorrhagic shock, our recent work on the application of mild hypothermia to pro!
long the «golden hour» is presented. Finally, a brief overview of our studies of a novel approach to the resuscitation of exsan!
guination cardiac arrest using emergency preservation for resuscitation (EPR) is provided. Key Words: Traumatic Brain
Injury, Resuscitation, Child Abuse, Inflicted Childhood Neurotrauma, Hemorrhagic Shock, Emergency Preservation and
Resuscitation, Apoptosis, Adenosine, Proteomics.
Introduction
First, let me congratulate Dr. Victor Moroz on
the occasion of the the 70th anniversary of the
Institute for General Reanimatology of the Russian
Academy of Medical Sciences. It is a truly amazing
accomplishment and one that I know would have had
special meaning to the late Dr. Peter Safar. There is a
rich and special history of interaction between the
late Drs. Peter Safar and Dr. Vladimir Negovsky, two
giants in the history of resuscitation. To commemo!
rate your anniversary celebration, I have provided
this review article, which presents a very brief histor!
ical overview of the interface between Drs. Safar and
Negovsky, followed by a description of the evolution
of the International Resuscitation Research Center
(IRRC) at the University of Pittsburgh School of
Medicine into the Safar Center for Resuscitation
Research!including an overview of some of our cur!
rent programs along with a selection of interesting
recent findings from our center.
The Safar!Negovsky Legacy
On September 5th 1962, Drs. Peter Safar chaired
a panel discussion at the First European
Anesthesiology Congress in Vienna, Austria on the
topic of «Controversial aspects of resuscitation».
Despite the challenges imposed by the cold war in the
early 1960s, Dr. Safar invited Dr. Vladimir Negovsky
to participate [1]!having read one of the English trans!
lated versions of Dr. Negovsky's work. That meeting
began a lifelong friendship and mutual admiration
between the two individuals who arguably became the
most important figures in the history of modern resus!
citation. Dr. Safar was impressed by four seminal
aspects of the pioneering work of Dr. Negovsky [2—4],
namely 1) his establishing a resuscitation research cen!
ter as early as 1937, 2) his early documentation of the
use of centripetal intra!arterial blood pumping and
mechanical ventilation to resuscitate that was initially
suggested by Russian physician Andreev in 1913, 3)
his coining of the term «reanimatology» and 4) his
description of the concept of «post!resuscitation dis!
ease». Dr. Safar's own pioneering work in resuscitation
(reviewed in 5) included the development of mouth!
to!mouth resuscitation, the assembly and dissemina!
tion of CPR, his work on the application of mild
hypothermia in cerebral resuscitation, his key role in
the development of emergency medicine services for
field resuscitation (which also included design of the
modern cabin configuration of the ambulance), semi!
nal studies on the pathomechanisms of human death in
natural and man!made disasters, and ultimately, his
spearheading the development of novel approaches to
resuscitation such as emergency preservation and
resuscitation (EPR). I believe that the mutual respect
and sharing of ideas between these two colleagues
influenced Negovsky to become more treatment ori!
ented and Safar to further study pathophysiologic
mechanisms [1] (Figure 1). The passing of these two
giants and great leaders in resuscitation — both during
the first week in August 2003 — represented a huge
loss for the resuscitation community. However, their
work has provided us with an incredibly rich founda!
tion upon which new approaches can be developed to
«save hearts and brains too good to die».
Transition from the IRRC to the Safar Center
In 1994, Dr. Peter Safar stepped down as direc!
tor of the IRRC, to focus his efforts more on his
research and a number of other projects. At that time,
Dr. Safar had established research programs at the
IRRC in the areas of cardiopulmonary arrest, hemor!
rhagic shock, and disaster medicine. I had the good
fortune of being named director after a local competi!
tion between three faculty investigators in the
Department of Anesthesiology and Critical Care
Medicine at the University of Pittsburgh. Over the
past 12 years, several new programs have been devel!
oped at the center and the landscape of several of the
existing programs has evolved. Currently, we have
programs in traumatic brain injury (TBI), cardiopul!
monary arrest, hemorrhagic shock, and ultra!
advanced resuscitation approaches such as EPR.
Several important new investigators have been added
to the center, and a number of key collaborators are
involved. New and/or enhanced roles for molecular
biology, free radical biology, proteomics, CNS injury
models, and rehabilitation research have emerged.
Our center has a multidisciplinary faculty which
spans the departments of Critical Care Medicine,
Neurological Surgery, Pediatrics, Surgery, Physical
Medicine and Rehabilitation, Emergency Medicine,
Anesthesiology, and Pathology. A synthesis of some of
the most exciting and important findings within each
of these programs is provided below. Finally, one for!
mer program is currently inactive, and that is the pro!
gram in disaster medicine. 
Current Investigation at the Safar Center for
Resuscitation Research 
Traumatic Brain Injury: Bench to bedside
This represents a new area of research that has
developed during the past 10 years. It has been the
most productive area of investigation in our center
and includes work !as principal investigator!by eight
faculty investigators, and numerous important col!
laborators and trainees. Currents studies in our cen!
ter are focused on mechanisms in the evolution of sec!
ondary damage including delayed neuronal death,
oxidative and nitrative stress, dopamine systems,
poly!ADP ribose polymerase (PARP), kinase! and
phosphatase!mediated events, serotonin pathways,
and endogenous neuroprotectants such as adenosine.
We and our collaborators have taken advantage of a
number of important new tools in this work on TBI,
including the use of a contemporary model of experi!
mental TBI!controlled cortical impact (CCI), the
application of novel magnetic resonance imaging
(MRI) tools such as perfusion imaging and non!inva!
sive assessment of macrophage accumulation in
injured brain, novel proteomic and oxidative
lipidomic approaches, and in vivo electrochemical
monitoring techniques like fast scan cyclic voltam!
metry, among others methods. We have used the CCI
model of TBI in both rats in mice for over sixty stud!
ies in experimental TBI. This model was developed
for use in rats by Dr. C. Edward Dixon, one of the
Safar Center faculty [6], and is both highly repro!
ducible, and well characterized. In addition, we have
developed several modifications of this model, most
notably the use of combined TBI plus secondary
hypoxemia [7]!which models the important combina!
tion of these insults that is often observed clinically
after TBI [8]. Finally, our group has led the way in
linking bench!bedside in the study of cellular and
molecular mechanism of secondary damage and
repair in human TBI. We have accomplished this
using two important resources, assessing biochemical
and molecular markers in cerebrospinal fluid (CSF)
drained through ventriculostomy catheters in the
treatment of intracranial hypertension in patients
(both adults and children) with severe TBI
[reviewed in 9], and by performing western analysis
and immunohistochemistry of brain tissue resected
emergently from critically ill patients with severe
TBI in the treatment of refractory intracranial hyper!
tension and impending herniation [10—12]. 
Mechanism of neuronal death
This area of investigation has been the focus of
Safar Center investigator, Dr. Robert Clark!who has
contributed a number of important reports in both
experimental and clinical TBI. Dr. Clark's most sig!
nificant contributions in this area have included the
first documentation of caspase!3 and caspase!1 activa!
tion in human head injury [10] (Figure 2), and early
descriptions of the role of both caspase activation and
apoptosis!initiating factor (AIF) release in experi!
mental TBI [13, 14]. Most recently Dr. Clark and his
group have published two reports in human TBI that
have substantially advanced our knowledge in this
area. First, Zhang et al [12] reported that the impor!
tant cell survival pathway linked to protein kinase B
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Figure 1. Vladimir Negovsky, «the father of reanimatology» and
Peter Safar in Moscow in the 1970s.
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(PKB, also know as Akt) is activated in human TBI.
PKB!when activated is phorphorylated and inhibits
the intrinsic (mitochondrial) pathway of apoptosis.
This is believed to be accomplished by PKB!mediated
phosphorylation and inactivation of downstream
death signals such as BAD and by phosphorylation
and activation of the pro!survival signal cyclic AMP
response element binding protein (CREB). Using
brain tissue samples from 15 patients with severe TBI,
Dr. Clark's group convincingly demonstrated that
PKB and its downstream signals are phosphorylated
and thus activated in human head injury!supporting a
role for this important pathway and suggesting that it
may be a target for therapeutic manipulation. These
findings have taken on even greater significance given
the recent work from the laboratory of Dr. Gary
Steinberg suggesting that mild therapeutic hypother!
mia may confer some of its benefit through the
enhancement of this pathway [15]. 
A second important recent publication from Dr.
Clark's laboratory by Satchell et al [16], reported
that levels of the key cellular apoptosis trigger
cytochrome C are increased in CSF of infants and
children with severe TBI!particularly in victims of
inflicted childhood neurotrauma (i. e., child abuse or
«shaken baby syndrome»). Because release of
cytochrome c has been shown to be a pivotal trigger
of the apoptotic cascade in a number of experimental
systems, this study of 67 infants and children sug!
gests that delayed neuronal death plays an important
role in pediatric TBI, and that this pathway may be a
particularly important therapeutic target in victims
of child abuse. Targeting delayed neuronal death
appears to represent an important therapeutic target
for the development of new therapies for TBI, partic!
ularly in infants and young children. 
Oxidative and nitrative stress
Dr. Hulya Bayir of the Safar Center, in collabo!
ration with Dr. Valerian Kagan, at the University of
Pittsburgh Center for Free Radical and Antioxidant
Health, have carried out a series of studies over the
past 5 years that has contributed significantly to our
understanding of the role of oxidative and nitrative
stress in experimental and clinical TBI [17—24].
Using a comprehensive battery of markers of oxida!
tive stress, Bayir et al [16] reported marked increases
in lipid peroxidation and depletion of endogenous
antioxidants such as ascorbate and total antioxidant
Figure 2. Example of bench to bedside molecular biology in human head injury from the laboratory of Dr. Robert Clark. Caspase!1 and
!3 proteins are expressed in pericontusional brain samples from patients after severe traumatic brain injury (TBI). Caspase!1 is involved
in synthesis of the pro!inflammatory cytokine interleukin!1, while caspase!3 is a critical enzyme in the apoptotic cell death cascade. A)
Pro!caspase!1 was reduced in patients after TBI compared with controls. The p10 fragment of caspase!1 was increased in patients after
TBI compared with controls. B) Preabsorption studies using the anti!caspase!1 p10 antibody incubated with or without the peptide
used to generate the antibody. C) Both caspase!3 and the p12 fragment of caspase!3 were increased in patients after TBI versus con!
trols. *p<0.05 vs. control, ROD, relative optical density. From Clark et al (10) with permission.
reserve in CSF samples in children with severe TBI.
Striking and concerning was the extent and progres!
sive nature of the ascorbate depletion in these
patients over the initial 5 days after severe TBI
(Figure 3). This report strongly suggests that one of
the mechanisms underlying the well recognized
heightened vulnerability of patients with severe TBI
to secondary brain insults in the intensive care unit,
reported by Gopinath et al [25], is loss of antioxidant
defenses. More recently, in preliminary studies, Dr.
Bayir — in collaboration with Dr. David Adelson and
his recent randomized controlled clinical trial of the
use of mild to moderate hypothermia in infants with
severe TBI, demonstrated that cooling significantly
attenuated the loss of antioxidants after TBI [22] —
suggesting that this mechanism accompanies the
reduction in intracranial pressure that is known to be
produced with the use of mild and moderate
hypothermia in clinical TBI. Finally, in recent studies
in our laboratory, Dr. Bayir has demonstrated, using
neuronal nitric oxide synthase knockout mice, that
the nitric oxide pathway in neurons!and likely specif!
ically in mitochondria!contribute importantly to the
nitration and inactivation of the important mito!
chondrial antioxidant enzyme Manganese superoxide
dismutase (MnSOD) [23, 24]. She similarly reported
that MnSOD nitration and inactivation occur in con!
tusion samples from humans with severe TBI [23].
This is another example of the type of bench!to!bed!
side work that we feel is important to enhancing our
understanding of cellular and molecular mechanism
of secondary injury in severe TBI. Additional
research on the role of oxidative and nitrative stress
in TBI is warranted.
Proteomics applications
One of the best methods currently available to
try to unravel the mechanism of secondary injury and
repair in the injured brain after TBI or cardiac arrest
is the use of proteomics. Using both 2!D gel and high!
throughput multiblot approaches allows the simulta!
neous investigation of many proteins, along with the
examination of critical protein post!translational
modification such as phosphorylation (Figure 4). Dr.
Larry Jenkins and his associates in our
center have contributed the initial appli!
cation of this contemporary technology
to the field of experimental TBI [26], the
first use of this method in a developmen!
tal TBI model [27], and early use in clin!
ical TBI [28]. In a manuscript in press
[27], Dr. Jenkins' group used a 2D differ!
ence gel electrophoresis (DIGE) method
to study the response to experimental
brain injury in the rat hippocampus at 14
days after CCI injury in developing (17
day!old) rats. Changes in a large number
of important proteins across numerous
functional categories such as energy
metabolism and mitochondrial function,
synaptic function, oxidative stress, and
cell stress and chaperone proteins were
identified. For example, 30% decreases
in pyruvate dehydrogenase E1 beta and
alpha subunits were noted, while the
glial stress protein GFAP was increased
over 300!fold. More recently, Gao et al
[28] used a 2D gel approach to study
CSF from infants and children with
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Figure 3. Effect of severe TBI on the antioxidant ascorbate con!
centration in CSF of infants and children. Ascorbate concentra!
tions were 3!, 8!, and 10!fold lower in subjects with TBI on d 1, d
2, and d 5—7, respectively, compared with controls (* — p<0.05 vs
control, # — p<0.05 vs TBI d 1). These findings strongly support
that the injured brain is depleted of endogenous antioxidants and
may be vulnerable to secondary oxidative insults in the intensive
care unit. From Bayir et al (10) with permission.
Figure 4. Proteomic assessment using large!format 2D immunoblots showing a
reduction in the number of phosphoproteins after experimental TBI in rats (135
spots) versus sham rats (209 spots). In addition to such general changes, spot can!
didates for a number of known protein substrates, such as forkhead transcription
factors (FKHR, FKHR1), phosphodiesterase!3!beta (PDE!3B), glucose trans!
porter protein 3 (GLUT3), and glucose transporter protein 4 (GLUT4), were pro!
posed on the basis of observed Mr and pI values. Comparable spot candidates for
FKHR, and FKHR1 phospho!immunoreactivity were not seen after CCI, with
considerable loss of phosphor!immunoreactivity in GLUT3 and GLUT4. This pow!
erful proteomic method demonstrates the ability to simultaneously assess changes
in multiple phosphorylated proteins after experimental TBI. From Jenkins et al
(26) with permission.
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either inflicted (child abuse) or non!inflicted (acci!
dental) TBI. He demonstrated unique increases in
the acute phase reactants such as haptoglobin iso!
forms in infants with accidental but not inflicted
TBI. This suggests that factors such as a delay in pre!
sentation or chronic or repeated injury may blunt the
traditional acute phase response in victims of TBI
from child abuse.
Adenosine
Our group, in collaboration with Dr. Edwin
Jackson of the University of Pittsburgh Center for
Clinical Pharmacology, has carried out a number of
studies demonstrating marked increased in levels of
adenosine in brain interstitial fluid and CSF after
both experimental and clinical TBI [29—32]. We
have also characterized some of the putative effects of
adenosine production in the injured brain, in both
our model systems and in humans [31, 33—36].
Adenosine is believed to play a critical endogenous
neuroprotectant role through effects at multiple
receptors including A1, A2a, A2b, and A3. For exam!
ple, adenosine, formed during the breakdown of ATP
in ischemic brain regions has important anti!excito!
toxic and anti!convulsant effects in brain in some
model systems, while, effects of adenosine at A2a and
A2b receptors can, among other effects, increase cere!
bral blood flow (CBF) [37, 38]. One can readily
envisage that reduced metabolic demands and
improved CBF represent valuable endogenous pro!
tectant effects early after brain injury from either
trauma or ischemia. 
We recently published two studies
that provide insight into the potential
neuroprotective role for adenosine in
TBI. First, we reported that early after
CCI, adenosine A1 receptor knockout
mice develop lethal status epilepticus
[36]. Status epilepticus has not been
noted by us or others in numerous stud!
ies with the mouse CCI model.
Nevertheless, it occurs in the A1 recep!
tor knockout mouse even when moder!
ate injury levels are used, and is seen
independent of gender. This finding sup!
ports a powerful anti!convulsant effect
of adenosine !mediated by effects at the
A1 receptor!after experimental TBI, and
may provided important clues toward
the development of highly targeted anti!
excitotoxic therapies. We have also
recently reported that non!selective and
A2a!selective adenosine agonists confer
powerful CBF promoting effects in both
the normal brain and early after CCI in
rats [35] (Figure 5). It is well recognized
that early after experimental and clinical
TBI, CBF is reduced [39, 40]. This has
suggested posttraumatic hypoperfusion
or ischemia as a putative therapeutic target. Using
novel perfusion MRI via the continuous arterial spin!
labeling method, we demonstrated that CBF could be
normalized early after injury by local injection of
non!selective adenosine agonists [35]. Thus, optimal
manipulation of the adenosine cascade may represent
an avenue for the early post!resuscitation phase in
human head injury and is an area of active investiga!
tion at our center.
Serotonin 1A receptor agonists
Another area of investigation targeting phar!
macological manipulation of injured brain after
severe TBI is via the serotonin transmitter system.
Recent work by Dr. Anthony Kline in our center
[41—43] has demonstrated beneficial effects of sero!
tonin 1A receptor agonists against both neuronal
cell death and functional impairments in rats after
CCI. Agents such as either repinotan or 8 hydroxy
DPAT!administered after the injury!were shown to
be effective [41—43]. Although the mechanism or
mechanisms underlying the beneficial effects of
serotonin 1A receptor agonists in TBI remain to be
determined, it may be more than coincidence that
these agents share important anti!excitotoxic prop!
erties with adenosine and adenosine A1 receptor
agonists, including the ability to hyperpolarize neu!
rons, decrease glutamate release via actions at pre!
synaptic glutamatergic terminals, and inhibit sodi!
um channels. This suggests that excitotoxic
pathways are of special importance early after TBI.
Finally, the possibility of synergism of serotonin and
Figure 5. Acute effects of injection of either sterile water vehicle (left three verti!
cal panels) or the selective adenosine 2A receptor agonist, CGS 21680 (6 nmol,
right three vertical panels) into the left dorsal hippocampus of uninjured rats on
cerebral blood flow (CBF) (mL100g!1 min!1) assessed by the continuous arterial
spin labeled magnetic resonance imaging (MRI) method. This contemporary MRI
method is able to non!invasively demonstrate dramatic increases in CBF in rat
brain by this adenosine A2a receptor agonist. From Kochanek et al (35) with per!
mission.
adenosine targeting therapies in experimental or
clinical TBI has not been investigated but might
represent an intriguing opportunity. 
MRI applications in experimental TBI 
MRI is a powerful tool for the investigation of
experimental TBI and cardiac arrest. We have collab!
orated extensively with Dr. Chien Ho and his
research group at the Pittsburgh NMR center for bio!
medical research at Carnegie Mellon University. We
have used novel perfusion MRI by the continuous
arterial spin!labeling method to measure CBF in rat
brain. This non!invasive method, which uses arterial
water as the label, is highly advantages in that it can
generate serial maps of CBF — allowing for temporal
and regional assessment. In a series of studies, we
have assessed CO2 reactivity after CCI [44], early
posttraumatic hypoperfusion [39], the effects of anes!
thesia on CBF [45], serial assessment of CBF and
blood!brain barrier permeability [46], study of CBF
at long outcome times!as late as one year after injury
[47], and the aforementioned studies of the effect of
adenosine receptor agonists [33, 35]. This year, we
expanded the application of this non!invasive
method of CBF assessment to the studies in mice
[48]. Successful adaptation of this method to the
study of mice allows for the investigation of a wealth
of transgenic and knockout animals, and we believe,
will provide considerable insight into the contribu!
tion of posttraumatic ischemia to the evolution of
secondary damage after TBI.
Inflicted childhood neurotrauma
An important problem in the field of pediatric
TBI is inflicted childhood neurotrauma (child abuse,
shaken baby syndrome). By assessing CSF from
infants and children with severe TBI, it has become
clear that victims of inflicted childhood neurotrauma
often exhibit a unique biochemical profile versus vic!
tims of accidental injures (motor vehicle accidents,
falls, etc). As previously discussed, victims of inflict!
ed childhood neurotrauma may exhibit a number of
unique biochemical and molecular features such as 1)
a failure to mount some aspects of the acute phase
response to injury such as an increase in haptoglobin
levels [28], 2) accentuated delayed neuronal death as
reflected by a late rise in cytochrome c levels [16] and
neuron specific enolase (NSE) levels [49] in CSF, and
3) exaggerated stress response as reflected by high
CSF levels of heat shock proteins such as HSP 70
[50], among others. These findings may reflect chron!
ic injury, delay in presentation, a propensity toward
apoptosis related to the young age of these victims
(they are almost always infants), and/or to the fre!
quent occurrence of hypoxemic episodes in these
patients from untreated seizures or apnea [51]. Our
findings suggest that treatment of inflicted childhood
neurotrauma in infants may benefit from therapies
effective in hypoxic!ischemic encephalopathy (such
as mild hypothermia) and possibly therapies target!
ing apoptosis !which may be responsible for delayed
neuronal death. 
We have also measured biomarkers of brain injury
(such as NSE) in serum in addition to CSF in an
attempt to identify victims of mild or moderate inflicted
TBI in an attempt to prevent misdiagnosis!which is an
important problem for general pediatricians or emer!
gency medicine physicians. In a recent report, Dr.
Rachel Berger, working on this area at our center and
Children's Hospital of Pittsburgh measured serum NSE
in 98 infants who presented with non!specific symptoms
that are often consistent with those seen in missed cases
of inflicted childhood neurotrauma (such as vomiting
without diarrhea or irritability) [52]. There was an
increase in serum NSE in 79% of the children diagnosed
with inflicted childhood neurotrauma and in 80% of the
children who, in retrospect, may have been additional
missed cases. The use of serum biomarkers, such as NSE,
may represent an important new diagnostic adjunct for
use in this setting [reviewed in 53].
The link between research in acute TBI and
rehabilitation
Our center has traditionally focused on the acute
and sub!acute phases after CNS injury!those most ger!
mane to resuscitation. However, faculty in our center in
the Departments of both Neurological Surgery and
Physical Medicine and Rehabilitation have been
focused recently, in part, on more delayed phases after
TBI. This was suggested as an important area for future
research by Professor Vladimir Negovsky in his
«Essays on Reanimatology» in 1980 [4]. Dixon et al
[54] reported on sustained cognitive deficits in rats
over a one year follow!up period after TBI produced by
CCI. More recently Drs. Amy Wagner and Anthony
Kline have been studying the effect of environmental
enrichment on long!term cognitive outcome in rats
after CCI. Environmental enrichment represents an
interesting strategy that models the use of rehabilita!
tion in the clinical setting. Environmental enrichment
has powerful beneficial effects on outcome. Wagner et
al [55] reported that the beneficial effect of environ!
mental enrichment on cognitive outcome was observed
only in males after CCI in rats!implying important gen!
der differences. Subsequent studies suggest that the
environmental enrichment effects on dopamine sys!
tems and neurotrophin production after experimental
TBI are also, in part, gender specific [56, 57]. These
studies represent on aspect of a novel approach to
studying therapies in experimental TBI, namely, assess!
ment of therapies relevant to rehabilitation in the sub!
acute or chronic phases after injury. Both drugs and cel!
lular therapies (such as stem cells) may have important
potential in helping the brain re!wire after injury. 
Cardiopulmonary arrest
Optimization of therapeutic hypothermia
after cardiopulmonary arrest
A major focuses of investigation in cardiopul!
monary arrest at the Safar Center is in optimizing the
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use of therapeutic hypothermia. Dr. Safar and a num!
ber of other investigators used of therapeutic
hypothermia in the late 1950s and early 1960s. Indeed,
therapeutic hypothermia was incorporated into the
«ABCs» of resuscitation in the early 1960s (Figure 6)
[58]. However, in that era, moderate (28—32°C)
rather than mild (23—35°C) hypothermia was used
and often for too long of a duration!leading to infec!
tions and other complications. Along with the classic
paper of Busto et al [59], Dr. Peter Safar's work in clin!
ically realistic experimental cardiac arrest launched
the re!assessment of mild cooling!which has led to pos!
itive clinical trials in both adults [60, 61], and new!
borns [62]. It is noteworthy that Dr. Fritz Sterz and his
investigative team at Vienna General Hospital in
Austria!an alumnus of our center!led the successful
European study of mild hypothermia after cardiac
arrest. These findings have led the American Heart
Association and the International Liaison committee
on resuscitation (ILCOR) to recommend mild cooling
for comatose survivors of cardiopul!
monary arrest. For more information on
the use of mild hypothermia in CNS
insults, we would suggest several reviews
and editorials [63—65]. 
Recently, we have carried out two
studies focused on defining the optimal
application of mild hypothermia. We test!
ed the efficacy of the application of mild
hypothermia during CPR rather than
after restoration of spontaneous circula!
tion!which is the approach that was effec!
tive in the aforementioned clinical trials in
both adults and infants. We used a sce!
nario that included ventricular fibrillation
(VF) followed by 3 min of no flow, 7 min
of basic life support (BLS) and 10 addi!
tional min of VF with simulated unsuc!
cessful advanced cardiac life support
(ACLS). We then randomized dogs to 20
min of either continued ACLS at nor!
mothermia, or moderate hypothermia
induced via venovenous extracorporeal
shunt cooling. Therapeutic hypothermia
induced during the arrest produced a dra!
matic beneficial effect!namely, normal
outcomes. In contrast, dogs maintained
normothermic developed multiple organ
failure and remained comatose [66]. More
recently, we reported that delaying the
application of hypothermia from 10 min to
20 min in the resuscitation greatly reduced
its effectiveness!suggesting a critical time
window for the optimal intra!arrest appli!
cation of cooling [67]. Coupled with the
published reports on success of post!arrest
cooling [60, 61] and the recent work of
Bernard et al [68], our findings suggests
that to optimize outcomes after cardiac arrest, cooling
during resuscitation should be promptly initiated!prob!
ably with a cold intravenous bolus!!and continued for
12—24 hours after resuscitation.
Asphyxial arrest!novel mechanistic insight
and treatment
Related to the strong link of several of our cen!
ter investigators to pediatric critical care medicine
and pediatric neurointensive care, there is consider!
able research in the area of pediatric resuscitation.
Dr. Ericka Fink, working in the laboratory of Robert
Clark has developed a new rat model of asphyxial car!
diopulmonary arrest mimicking the pediatric condi!
tion [69]. In that model, anesthetized rats 17 days of
age are subjected to an asphyxial insult that rapidly
leads to full cardiopulmonary arrest. A total insult
duration of 8.5 min is used, and results — after resus!
citation using chest compressions, epinephrine, and
sodium bicarbonate administration!in survival with
neuronal death in selectively vulnerable brain regions
Figure 6.  Initial description of the ABCs of resuscitation by Dr. Peter Safar in this
classic publication in the Journal of the Iowa Medical Society.  Note that Dr. Safar
recommended the use of hypothermia for victims that fail to promptly recover in
this early 1960s, and had already incorporated this approach into his clinical deci!
sion tree.
(Figure 7). This model has now been used in a series
of studies to evaluate hypothermia [70] along with a
number of novel therapies targeting both oxidative
stress and poly!ADP ribose polymerase activation
[71, 72]. This is an area of high activity at our center
and the model is an excellent one which shows great
promise both for studying mechanisms and screening
novel therapies. 
Hemorrhagic shock
Work in the area of hemorrhagic shock in our
center is under the direction of Dr. Samuel
Tisherman, a trauma surgeon with critical care exper!
tise, and is focused on novel approaches to prolong
the «golden hour». The use of mild hypothermia in
this regard has been evaluated in a series of studies in
rats and it has been shown to powerfully delay and/or
prevent acute death [73—77]. These studies have also
suggested a systemic effect of hypothermia rather
than a local effect on gut alone, since isolated cooling
of the gut was not effective [76]. Similarly, the bene!
fit of mild cooling does not appear to result from a
reduction in cytokines [77]. One recent study from
Dr. Tisherman's group is particularly noteworthy.
Using a clinically relevant, pig model with trauma
and intensive care, Wu et al [78] tested the hypothe!
sis that mild hypothermia, induced with intravenous
cold saline (ice cold or room temperature) would
improve survival after hemorrhagic shock in pigs.
Using a model of venous blood withdrawal over 3
hours and spleen transection, three groups were com!
pared: 1) normothermia (38°C), induced with
warmed saline; 2) mild hypothermia (34°C) induced
with intravenous infusion of iced saline; and 3) mild
hypothermia (34°C), induced with room temperature
saline. After the shock phase, shed blood was
returned and intensive care was continued to 24
hours. Remarkably, the hypothermia group in which
cooling was achieved with room temperature saline
exhibited the highest survival rate. Use of iced saline
administration in shock, reduced the fluid required to
achieve target blood pressure, but may appears to
have maintained blood pressure at the expense of
vasoconstriction and increased serum lactate levels.
Thus, mild hypothermia during hemorrhagic shock,
induced by infusion of room temperature saline,
improves survival in a clinically relevant model of
hemorrhagic shock and trauma. However, the use of
iced saline in this model had detrimental effects.
These findings suggest that optimal methods for
induction of hypothermia must be addressed for each
potential indication, e. g. cardiac arrest versus TBI
versus hemorrhagic shock. 
Emergency preservation and resuscitation
(EPR)
Exsanguination cardiac arrest has an extremely
poor prognosis [79], likely related at least in part to
the limited effectiveness of conventional resuscita!
tion methods (i. e., CPR, BLS and ACLS) in this set!
ting. This form of arrest is common among combat
casualties and can also be seen in some cases of civil!
ian trauma. As previously discussed, some of Dr.
Negovsky's pioneering work focused on the problem
of exsanguination cardiac arrest and used an intra!
arterial injection of oxygenated blood plus epineph!
rine targeting the resuscitation of exsanguinated
wounded soldiers (reviewed in 3). During the last 15
years of his life, Dr. Safar worked to develop a novel
approach to this otherwise refractory form of arrest.
He initially termed this approach «Suspended ani!
mation for delayed resuscitation» [80]. The
approach was developed in a dog model of exsan!
guination cardiac arrest and used a rapid aortic flush
of ice cold saline (with jugular venous drainage) to
promptly (within 15—20 minutes) achieve a state of
profound hypothermic preservation (Figure 8).
Successful emergency preservation for periods of
between 1 and 3 hours would allow transport of the
casualty to the far forward treatment facility in the
military setting or trauma bay in the civilian setting
where surgical repair could take place followed by
delayed resuscitation using cardiopulmonary bypass.
In a series of reports, we were able to achieve initial!
ly between 30 min and 1 hour of preservation and!
eventually — 2 hours of preservation with favorable
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Figure 7.  Electrocardiogram, blood pressure, and electroencephalogram (EEG) monitoring in a typical postnatal day 17 rat before, dur!
ing, and after 8 minutes of asphyxial cardiac arrest.  Partial recovery of EEG is seen after a 2!min anesthetic washout.  Return of spon!
taneous circulation (ROSC) occurs here at 22 seconds postresuscitation.  Note that the monitor speed was changed at several positions
in the tracing. This model is useful for studying mechanisms and novel therapies in an experimental setting mimicking cardiopulmonary
arrest in young children. CPR, cardiopulmonary resuscitation, BP, blood pressure.  From Fink et al (69) with permission.
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outcome [81—83]. Some of our most recent studies
suggest that 3 hours of EPR induced during exsan!
guination cardiac arrest may be achievable [84]. 
A recent publication on this topic by our center
is noteworthy. Wu et al [85] tested whether or not
this approach could be successful if exsanguination
cardiac arrest was preceded by about 2 hours of hem!
orrhagic shock. In that study, good neurological out!
come was achieved after a 1 hour period of hypother!
mic preservation even if it was preceded by 2 hours of
hemorrhagic shock. Favorable outcome could only be
achieved if the period of preservation was followed
with 36 hours of mild hypothermia followed by slow
re!warming. Dr. Drabek in our group has also recent!
ly developed a rat model of EPR to both carry out
molecular studies of the mechanisms of hypothermic
preservation and to screen novel therapies [86].
This novel approach to resuscitation has been
named EPR in Dr. Safar's honor and may represent
the new CPR for cases of refractory arrest!particular!
ly those due to exsanguination. Finally, recent studies
by Behringer in Vienna have begun to apply this
approach to cases of refractory normovolemic cardiac
arrest [87] and have built on Dr. Safar's suggestions
of an even broader potential application of EPR. A
multi!center clinical feasibility trial of EPR in the
setting of civilian trauma resulting in exsanguination
cardiac arrest is in the planning stages, and an initial
consortium meeting of interested trauma centers was
held by Dr. Tisherman in 2005 in Pittsburgh. 
Conclusions and future directions
Building on the remarkable foundation laid
by Dr. Peter Safar, and capitalizing on many of
the important clues in the seminal
work of Dr. Vladimir Negovsky, the
Safar Center for Resuscitation
Research continues to better under!
stand the pathobiology of clinical
conditions that require resuscitation,
and ultimately improve therapies.
Over the past 12 years, the scope of
the work at the Safar Center has
expanded to include programs in the
areas of TBI and rehabilitation, and
the importance of pediatric CNS
injury and resuscitation have also
increased in scope. Future investiga!
tion at the Safar Center, I believe, will
include additional work on mecha!
nisms in the evolution of secondary
damage after TBI, cardiac arrest, and
hemorrhagic shock, and development
and translation of novel therapies for
these conditions. New tools such as
proteomics, lipidomics, genomics and
advanced MRI applications are
important to our ability to better
understand the cybernetic post!resus!
citation disease, first introduced by Dr. Negovsky,
which follows these severe insults. We are also
beginning to put substantial effort into studying
blast injury and the combination of TBI and hem!
orrhagic shock. These conditions are important,
albeit very unfortunate, consequences of terrorist
attacks with improvised explosive devices in both
the military and civilian sectors [88, 89]. We are
currently investigating novel resuscitation fluids
and therapies in experimental models of these
important conditions. We are also placing
increased emphasis on the importance of rehabili!
tation, and the need for research in that area.
Finally, we hope to pursue additional work in
ultra!advanced resuscitation techniques, includ!
ing EPR, and look forward to the challenge of an
initial clinical trial in exsanguination cardiopul!
monary arrest.
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Figure 8. Schematic outlining the overall strategy used in the novel Emergency
Preservation and Resuscitation (EPR) strategy recently developed at the Safar
Center as a potential new approach for the treatment of exsanguination cardiac
arrest. Preservation of the exsanguinated trauma victim, via rapid aortic infusion
of ice!cold aortic flush (targeting a brain [tympanic] temperature of ~7°C), for up
to 2—3 hours may allow transport to a military field surgical hospital or civilian
trauma bay with surgical capability for emergent damage control surgery followed
by delayed resuscitation using cardiopulmonary bypass. This approach has the
potential to salvage some otherwise lethally wounded trauma victims and is ready
for clinical feasibility trials.
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